Search

everythinglearnresearchcommunity

for

Search:↓

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Labrasol® in phospholipid vesicles improves minoxidil delivery to the skin, potentially aiding hair growth treatments.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Rodent models of PCOS show some similar and some different lipid changes compared to humans.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Finasteride may help treat Neutrophil Actin Dysfunction by reducing LSP1 gene activity.

The Ysc84/SH3yl1 protein family is important for cell movement and the process of taking in materials by interacting with actin and cell membranes.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Adding a second method to PROTACs could improve cancer treatment.

Blocking certain fat production can reverse skin inflammation and hair loss.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

New progesterone-based compounds can block male hormones.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.